STAT

JANUARY 6, 2024

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor  here , or find the submission form at the end of any First Opinion essay. “ There’s a public health crisis lurking in our data: the Census option ‘some other race ,’” by Juan Carlos Gonzalez Jr.

264

264

Safe Biologics

JANUARY 6, 2024

In November, the Centers for Medicare and Medicaid Services (CMS) announced a Proposed Rule that would permit Medicare Part D plan sponsors to substitute non-interchangeable biosimilars in place of the biologic medicines now used to treat many chronic conditions such as rheumatoid arthritis, Crohn’s disease and cancer. Read ASBM’s statement on the announcement here.

Biosimilars 100

Biosimilars 100

The Guardian - Pharmaceutical Industry

JANUARY 6, 2024

Many firms see the dire forecasts as ‘overblown’ but they know they will have to adapt products to make ‘every bite must count’ On a drizzly morning Luton’s takeaways are preparing for the lunchtime rush. McDonald’s is busy with shoppers, while chains from Subway to German Doner Kebab are opening their doors for the approaching army of hungry stomachs.

Hospitals 105

Hospitals Diabetes 105

BioPharma Dive

JANUARY 6, 2024

The Emeryville, California- based gene therapy developer has several preclinical programs in development with Moderna, Ionis and Affini-T.

83

83

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Drug Patent Watch

JANUARY 6, 2024

This chart shows the drugs with the most patents in Philippines. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Philippines? appeared first on DrugPatentWatch - Make Better Decisions.

59

59

Express Pharma

JANUARY 6, 2024

The Ministry of Health and Family Welfare (MoHFW) announced revised rules under Schedule M of the Drugs and Cosmetics Rules, 1945 , through a notification published in the Gazette of India. The Central government, along with the Drugs Technical Advisory Board (DTAB), notified the amended rules under the Drugs (Amendment) Rules, 2023. The revised Schedule M includes the introduction of a pharma quality system (PQS), quality risk management (QRM), product quality review (PQR), and specific guideli

102

102